Sell Cochlear says Goldman Sachs in analysis release to market
MELBOURNE: Equity analysts at Goldman Sachs say hearing implant maker Cochlear is a “high quality
MELBOURNE: Equity analysts at Goldman Sachs say hearing implant maker Cochlear is a “high quality